AI-generated summary
The authors tested whether red helium-neon laser therapy given before ionizing radiation affected normal human lymphoblast cells and human leukemia cells grown in the laboratory. Laser exposure blocked radiation-related decline in normal cells but not in leukemia cells, which became more sensitive to radiation. The authors conclude the laser did not protect malignant cells and may have sensitized them, based on cell studies only.
- Who or what was studied
- Cultured normal human lymphoblasts (TK6) and human leukemia cells (HL60); no human patients.
- Wavelengths
- 632 nm
- Limits stated in the abstract
- The study used cultured cells rather than patients or animals, so its findings may not apply to clinical treatment.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Power
- 35 mW
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Dose, Oral mucositis, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.